Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Go back to Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026| (NASDAQ: ROIV) | Delayed: 35.01 -0.09 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.10 | 52 Week High | $ | |||
| Open | $35.23 | 52 Week Low | $ | |||
| Day High | $35.59 | P/E | N/A | |||
| Day Low | $34.80 | EPS | $ | |||
| Volume | 4,043,255 | |||||
| (NASDAQ: ROIV) | Delayed: 35.01 -0.09 (0.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.10 | 52 Week High | $ | |||
| Open | $35.23 | 52 Week Low | $ | |||
| Day High | $35.59 | P/E | N/A | |||
| Day Low | $34.80 | EPS | $ | |||
| Volume | 4,043,255 | |||||

